2019
DOI: 10.1158/1055-9965.epi-19-0106
|View full text |Cite
|
Sign up to set email alerts
|

Medical Conditions and Modifiable Risk Factors for Myelodysplastic Syndrome: A Systematic Review

Abstract: Background: The aim of this systematic review was to evaluate medical conditions and modifiable risk factors for myelodysplastic syndromes (MDS) using the 2001 or 2008 World Health Organization (WHO) diagnostic criteria. Methods: PubMed, MEDLINE, and Scopus databases were searched for studies published between January 2001 and August 2017. Study characteristics and findings were abstracted for each article. Results: Thirteen articles (4 cohort, 9 case-control) met the inclusion criteria. Smoking and alcohol us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 52 publications
(88 reference statements)
0
3
0
1
Order By: Relevance
“…Several subtypes have been consistently associated with treatments (i.e. radiation, alkylating agents or topoisomerase II inhibitors) 37 , while environmental epidemiological studies suggest a potential role of obesity, tobacco exposure, autoimmune disorders, and infections in myelodisplastic 38 or myeloproliferative diseases 39 . However, neither these factors, nor the genetic alterations currently described 40 , can explain the large variability in the incidence of these neoplasms 2 .…”
Section: Discussionmentioning
confidence: 99%
“…Several subtypes have been consistently associated with treatments (i.e. radiation, alkylating agents or topoisomerase II inhibitors) 37 , while environmental epidemiological studies suggest a potential role of obesity, tobacco exposure, autoimmune disorders, and infections in myelodisplastic 38 or myeloproliferative diseases 39 . However, neither these factors, nor the genetic alterations currently described 40 , can explain the large variability in the incidence of these neoplasms 2 .…”
Section: Discussionmentioning
confidence: 99%
“…Una revisión sistemática de 33 estudios encontró una relación positiva entre el SMD y la obesidad (índice de masa corporal o IMC>30), el tabaquismo (mayor en activos con una exposición de un paquete/año o más), las enfermedades autoinmunes, la anemia, el antecedente de infecciones adquiridas en comunidad en el año previo y el antecedente de uso de fármacos antituberculosos. (15) El SMD asociado a la exposición a benceno se ha estudiado principalmente en trabajadores de la industria petrolera. Un análisis internacional que incluyó personal de Australia, Canadá y Estados Unidos, encontró un OR de 4.3 para el desarrollo de SMD en individuos con una exposición acumulada mayor a 2.93 ppm-año, respecto a aquellos con una menor o igual a 0.348 ppm-año.…”
Section: Etiologíaunclassified
“…However, tea and dietary isoflavone intake are associated with lower risk of acquiring MDS. 9 , 10 , 11 , 12 , 13 , 14 , 15 Nevertheless, others have identified associations with inherited genetic abnormalities such as Fanconi's anaemia, bloom syndrome, ataxia telangiectasia and other haematological disorders, including paroxysmal nocturnal haemoglobinuria (PNH) and congenital neutropenia. 16 , 17 Tobacco smoking is a major source of non‐occupational benzene exposure and it is well documented that cigarette smoke contains large number leukaemia causing agents of which benzene is the most relevant.…”
Section: Introductionmentioning
confidence: 99%
“…Several risk factors such as high body mass index (BMI) and obesity, less physical activity, autoimmunity are also found to have an association with the occurrence of MDS. However, tea and dietary isoflavone intake are associated with lower risk of acquiring MDS 9–15 . Nevertheless, others have identified associations with inherited genetic abnormalities such as Fanconi's anaemia, bloom syndrome, ataxia telangiectasia and other haematological disorders, including paroxysmal nocturnal haemoglobinuria (PNH) and congenital neutropenia 16,17 .…”
Section: Introductionmentioning
confidence: 99%